Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Pharminox Ltd.
Cancer Research UK has granted an exclusive global licence to Pharminox for its programme that targets telomeres and the enzyme that maintains them, telomerase.
Start-Up showcases the following recently launched companies: Hemocellular Development Corp., Immunetrics Inc., Pharminox Ltd. and Predictive Technology Inc.
IP2IPO Ltd. aims to facilitate technology transfer from UK universities, securing funding and advice to help commercialize intellectual property (IP).